XiaoxianLiMD

Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Li?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting!
Read the latest clinical news, personalized to your specialty.

Office
6565 Fannin St
# M227
Houston, TX 77030
Phone+1 713-441-3490

Fax+1 713-793-1603

Dr. Xiaoxian Li, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Georgia and California. He is affiliated with Emory University Hospital.

University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2012 - 2013
Methodist Hospital (Houston)Residency, Pathology-Anatomic and Clinical, 2007 - 2011
Beijing Medical UniversityClass of 1997

PubMed

1079 citations
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton, Xiaoxian Li, Melissa D. Landis, J. Michael Dixon, Veronique Neumeister
Proceedings of the National Academy of Sciences of the United States of America. 2009-08-18
56 citations
Role of RPL39 in Metaplastic Breast Cancer
Bhuvanesh Dave, Daniel D. Gonzalez, Zhi Bin Liu, Xiaoxian Li, Helen Wong
Journal of the National Cancer Institute. 2017-06-01
88 citations
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.
Bhuvanesh Dave, Sergio Granados-Principal, Rui Zhu, Stephen C. Benz, Shahrooz Rabizadeh
Proceedings of the National Academy of Sciences of the United States of America. 2014-06-17

Prognostic Value of Programmed Cell Death Ligand-1 Expression in Breast CancerDecember 4th, 2020
Molecular Pathology Selected AbstractsMarch 22nd, 2024